| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|---|---|---|---|---|---|---|
| 1 | 1961 | Twenty years of antibiotics--a review. |
| + | - | nl | Indian J Physiol Pharmacol 5(-):91-112 (1961) |
| 2 | 1991 | Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. |
| + | - | nl | Antimicrob Agents Chemother 35(10):1953-9 (1991) Nix DE |
| 3 | 1991 | Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. |
| + | - | nl | Antimicrob Agents Chemother 35(10):1947-52 (1991) |
| 4 | 1977 | Genetics of antibiotic production. |
| + | - | nl | Bacteriol Rev 41(3):595-635 (1977) |
| 5 | 1999 | Plant products as antimicrobial agents. |
| + | - | nl | Clin Microbiol Rev 12(4):564-82 (1999) |
| 6 | 1998 | Gene therapy for infectious diseases. |
| + | - | nl | Clin Microbiol Rev 11(1):42-56 (1998) |
| 7 | 1990 | Discovery and development of new antimicrobial agents. |
| + | - | nl | Clin Microbiol Rev 3(1):13-31 (1990) |
| 8 | 2008 | Currently available antimicrobial agents and their potential for use as monotherapy. |
| + | - | nl | Clin Microbiol Infect 14 Suppl 6():30-45 (2008) Peterson LR |
| 9 | 2008 | What's new and not so new on the antimicrobial horizon? |
| + | - | nl | Clin Microbiol Infect 14 Suppl 6():19-29 (2008) French GL |
| 10 | 2008 | New antimicrobial agents for the treatment of Gram-positive bacterial infections. |
| + | - | nl | Clin Microbiol Infect 14(5):411-20 (2008) Aksoy DY |
| 11 | 2005 | The need for new therapeutic agents: what is the pipeline? |
| + | - | nl | Clin Microbiol Infect 11 Suppl 3():36-42 (2005) Shah PM |
| 12 | 2004 | Antimicrobial drug development--the past, the present, and the future. |
| + | - | nl | Clin Microbiol Infect 10 Suppl 4():23-31 (2004) Powers JH |
| 13 | 2009 | Domains in bacterial membranes and the action of antimicrobial agents. |
| + | - | nl | Mol Biosyst 5(6):580-7 (2009) Epand RM |
| 14 | 2006 | Streptomyces inside-out: a new perspective on the bacteria that provide us with antibiotics. |
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 361(1469):761-8 (2006) Chater KF |
| 15 | 1972 | Complications of antibiotic therapy. |
| + | - | nl | Calif Med 117(5):24-48 (1972) |
| 16 | 1972 | Practical use of penicillin, cephalosporin and aminoglycoside antibiotics. |
| + | - | nl | Calif Med 117(4):17-27 (1972) |
| 17 | 2009 | Recent advances in the chemistry and biology of naturally occurring antibiotics. |
| + | - | nl | Angew Chem Int Ed Engl 48(4):660-719 (2009) |
| 18 | 2006 | Newer antibiotics for serious gram-positive infections. |
| + | - | nl | Cleve Clin J Med 73(9):847-53 (2006) |
| 19 | 2011 | General principles of antimicrobial therapy. |
| + | - | nl | Mayo Clin Proc 86(2):156-67 (2011) |
| 20 | 2008 | The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile. |
| + | - | nl | Clin Infect Dis 46(4):491-6 (2008) |
| 21 | 2008 | Small molecule inhibition of microbial natural product biosynthesis-an emerging antibiotic strategy. |
| + | - | nl | Chem Soc Rev 37(7):1320-9 (2008) |
| 22 | 2002 | Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. |
| + | - | nl | Clin Microbiol Rev 15(1):95-110 (2002) |
| 23 | 2002 | Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. |
| + | - | nl | Clin Microbiol Rev 15(4):647-79 (2002) |
| 24 | 2010 | Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. |
| + | - | nl | Clin Microbiol Rev 23(4):858-83 (2010) |
Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth
All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.